Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Behavioural pharmacology of 5-HT3 receptor ligands.

Barnes JM, Barnes NM, Cooper SJ.

Neurosci Biobehav Rev. 1992 Spring;16(1):107-13. Review.

PMID:
1553101
2.

Serotonin and psychiatric disorders. A key to new therapeutic approaches.

Costall B, Naylor RJ.

Arzneimittelforschung. 1992 Feb;42(2A):246-9. Review.

PMID:
1586395
3.

The psychopharmacology of 5-HT3 receptors.

Costall B, Naylor RJ, Tyers MB.

Pharmacol Ther. 1990;47(2):181-202. Review.

PMID:
2203069
4.

Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.

Costall B, Naylor RJ.

Pharmacol Toxicol. 1992 Dec;71(6):401-15. Review.

PMID:
1362267
5.

Serotonin receptors as potential targets for modulation of nicotine use and dependence.

Fletcher PJ, LĂȘ AD, Higgins GA.

Prog Brain Res. 2008;172:361-83. doi: 10.1016/S0079-6123(08)00918-7. Review.

PMID:
18772042
6.

Anxiolytic potential of 5-HT3 receptor antagonists.

Costall B, Naylor RJ.

Pharmacol Toxicol. 1992 Mar;70(3):157-62. Review.

PMID:
1349746
7.

Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists.

Wolf H.

Scand J Rheumatol Suppl. 2000;113:37-45. Review.

PMID:
11028830
8.

Pharmacological properties and functions of central 5-HT3 receptors.

Costall B, Naylor RJ.

Therapie. 1991 Nov-Dec;46(6):437-44. Review.

PMID:
1840228
9.

The role of 5-HT3 receptors in drug dependence.

Grant KA.

Drug Alcohol Depend. 1995 May;38(2):155-71. Review.

PMID:
7671767
10.

5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system.

Kilpatrick GJ, Hagan RM, Gale JD.

Behav Brain Res. 1996;73(1-2):11-3. Review.

PMID:
8788470
11.

Serotonergic mechanisms in anxiety.

Eison AS, Eison MS.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jan;18(1):47-62. Review.

PMID:
8115673
12.

5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic.

Lovinger DM.

Neurochem Int. 1999 Aug;35(2):125-30. Review.

PMID:
10405996
13.

Behavioral studies of serotonin receptor agonists as antidepressant drugs.

Lucki I.

J Clin Psychiatry. 1991 Dec;52 Suppl:24-31. Review.

PMID:
1684363
14.

The classification of 5-hydroxytryptamine receptors.

Mylecharane EJ.

Clin Exp Pharmacol Physiol. 1989 Jun;16(6):517-22. Review.

PMID:
2670359
15.

5-HT3 receptors and central effects of ethanol.

Kostowski W.

Pol J Pharmacol. 1996 May-Jun;48(3):243-54. Review.

PMID:
9112659
16.

5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.

Tyers MB.

Therapie. 1991 Nov-Dec;46(6):431-5. Review.

PMID:
1840227
17.

5-HT3 receptors: pharmacologic and therapeutic aspects.

Gyermek L.

J Clin Pharmacol. 1995 Sep;35(9):845-55. Review.

PMID:
8786244
19.

Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.

Di Giovanni G, Di Matteo V, Esposito E.

Indian J Exp Biol. 2002 Dec;40(12):1344-52. Review.

PMID:
12974395
20.

5-HT1 receptors and behavior.

Lucki I.

Neurosci Biobehav Rev. 1992 Spring;16(1):83-93. Review.

PMID:
1553109

Supplemental Content

Support Center